Orchestrating T and NK cells for tumor immunotherapy via NKG2A-targeted delivery of a de novo designed IL-2Rβγ agonist. - Chen, Jie; Ren, Enhui; Tao, Ze; Lu, Hongyu; Huang, Yunchuan; Li, Jing; Chen, Yuzhe; Chen, Zhuo; She, Tianshan; Yang, Hao; Zhu, Hong; Lu, Xiaofeng (Drug Delivery, 2025)